Hologic, Inc. in the news
Medical Technology Women's Health
Tamtam found 20 recent articles about Hologic, Inc..
- Hologic stock gains as merger terms value shares near 52-week high
Hologic's stock gains as its merger terms value shares near a 52-week high, reflecting strong market alignment and analyst expectations.
- Hologic stock heads into the open after a 2.1% drop
Hologic's stock dropped 2.1% to $76.07 on September 8, 2026, influenced by broader market declines due to rising oil prices and geopolitical concerns.
- Hologic stock holds near 52-week high as valuation and margins draw focus
Hologic's stock is near its 52-week high, supported by solid profitability and a strong balance sheet, but analyst targets suggest limited further upside.
- Hologic, Inc. Data Breach Investigation
Attorneys are investigating a potential class action lawsuit against Hologic, Inc. due to an unconfirmed data breach claim by the hacker group MetaEncryptor.
- Metaencryptor Targets Medical Leader Hologic, Inc.
Hologic, Inc., a medical technology company specializing in women’s health, was targeted by the Metaencryptor ransomware group on September 7, 2026, with a threat to leak sensitive data.
- Hologic stock trades near 52-week high on steady demand
Hologic's stock is trading near its 52-week high at $76.07 with a market capitalization of $16.97 billion, reflecting investor confidence in its women's health diagnostics and surgical technologies.
- Hologic stock holds near 52-week high after strong earnings
Hologic's stock price remains near its 52-week high, driven by solid financial performance and strong investor confidence in its diagnostic products.
- Fluent Pro Fluid Management System Wins IDEA Design Award
Hologic's Fluent Pro Fluid Management System won an IDEA Design Award, recognized for its user-centric design and intuitive operation in hysteroscopy procedures.
- Hologic stock holds near 52-week high as market values diagnostics growth
Hologic's stock is trading near its 52-week high, driven by strong market confidence in its diagnostics growth and significant demand in diagnostic testing.
- Hologic stock moves as Blackstone TPG buyout offer progresses
Hologic's stock is under scrutiny due to a private equity buyout offer and strong financial performance, with shares trading near the proposed acquisition price.
- Hologic stock holds near a 52-week high as revenue stays firm
Hologic's stock trades near its 52-week high, supported by firm revenue and a strong diagnostics and imaging product base, though valuation hinges on future earnings.
- Hologic stock steadies near its 52-week high
Hologic's stock is near its 52-week high despite a recent earnings miss, with the company focused on women's health diagnostics.
- Hologic stock trades close to 52-week high as earnings growth supports valuation
Hologic's stock is near its 52-week high, supported by expected earnings growth, despite a recent EPS miss and a premium valuation.
- NH Justices Reject Hologic's Capital Loss Carryback
Hologic Inc. was denied by New Hampshire Justices in its attempt to use a capital loss carryback from one group member to offset another's gains.
- Hologic stock holds near a takeover price as shares trade at $76
Hologic's stock is trading near its 52-week high of $76 due to a takeover bid, with a market value of $16.97 billion.
- Hologic’s Business Tax Method Nixed by New Hampshire Justices
Hologic Inc. cannot offset one subsidiary's capital gains with another's capital losses for New Hampshire business tax, according to the state Supreme Court.
- NH Justices Reject Hologic's Capital Loss Carryback
Hologic Inc. was barred by New Hampshire Justices from using a capital loss carryback from one group member to offset gains of another group member.
- Hologic stock holds at record 52-week high as tax ruling draws attention
Hologic's stock is at a 52-week high, propelled by growth in women's health, despite a recent New Hampshire tax ruling creating a minor legal overhang.
- Hologic stock holds close to 52-week high as investors digest January earnings
Hologic's stock is trading close to its 52-week high, supported by strong earnings and its focus on women's health medical technology.
- Hologic stock holds steady as earnings outlook points to modest growth
Hologic's stock is trading at the high end of its 52-week range, with analysts maintaining a "Hold" rating and anticipating modest earnings growth.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Hologic, Inc.?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies